Concepedia

Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis

Eva Julià, Xavier Montalbán, Hammad Alzayat, Shohreh Issazadeh‐Navikas, Robert Goertsches, Roland Martinꝉ, Manuel Comabella

Journal of Neuroimmunology · 2006 · 18 citations · 25 references

DOI

Concepts

References

25

Defining the clinical course of multiple sclerosis

Fred Lublin, Stephen C. Reingold · Neurology · 1996 · 3.7K citations

, , +17

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon et al. · Annals of Neurology · 1996 · 2.4K citations

, , +12

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

Torben Lykke Sørensen, Marie Tani, Jakob Schmidt Jensen et al. · Journal of Clinical Investigation · 1999 · 1K citations · Full text

, , +17

CCR5 <sup>+</sup> and CXCR3 <sup>+</sup> T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions

Konstantin Balashov, James B. Rottman, Howard L. Weiner et al. · Proceedings of the National Academy of Sciences · 1999 · 847 citations · Full text

, , +17

Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions

Julie E. Simpson, Jia Newcombe, M. L. Cuzner et al. · Journal of Neuroimmunology · 1998 · 409 citations

, , +17